Abstract
Abstract
Identifying the key toxic players within an in-vivo toxic syndrome is crucial to develop targeted therapies. Here, we established a novel method that characterizes the effect of single substances by means of an ex-vivo incubation set-up. We found that primary human spermatozoa elicit a distinct motile response on a (uremic) toxic milieu. Specifically, this approach describes the influence of a bulk toxic environment (uremia) as well as single substances (uremic toxins) by real-time analyzing motile cellular behavior. We established the human spermatozoa-based toxicity testing (HSTT) for detecting single substance-induced toxicity to be used as a screening tool to identify in-vivo toxins. Further, we propose an application of the HSTT as a method of clinical use to evaluate toxin-removing interventions (hemodialysis).
Funder
Västerbotten County Council (ALF Support), Njurföreningen Västerbotten
Deutsche Forschungsgemeinschaft
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Vanholder, R. et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transpl 20, 1048–1056 (2005).
2. Vanholder, R. et al. Review on uremic toxins: Classification, concentration, and interindividual variability. 63 (2003).
3. Duranton, F. et al. Normal and Pathologic Concentrations of Uremic Toxins. J Am Soc Nephrol 23, 1258–1270 (2012).
4. Almeras, C. & Argilés, À. PROGRESS IN UREMIC TOXIN RESEARCH: The General Picture of Uremia. Semin Dialysis 22, 329–333 (2009).
5. Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. New Engl. J Medicine 351, 1296–1305 (2004).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献